| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 05/21/2004 | WO2003084935A3 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases |
| 05/21/2004 | CA2507406A1 Compounds useful as inhibitors of jak and other protein kinases |
| 05/21/2004 | CA2506772A1 Compositions useful as inhibitors of jak and other protein kinases |
| 05/21/2004 | CA2502429A1 Antiinflammation agents |
| 05/21/2004 | CA2502302A1 Quinazolinone compounds as calcilytics |
| 05/20/2004 | US20040097525 Novel Compounds |
| 05/20/2004 | US20040097508 Novel heterocyclically substituted amides, their preparation and use |
| 05/20/2004 | US20040097503 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040097495 Method for treating fibrotic diseases or other indications IIIC |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/20/2004 | US20040097485 For therapy and prophylaxis of disease or condition associated with inflammation, a metabolic disorder, infection, cancer or an immune disease or condition |
| 05/20/2004 | US20040097376 Controlling weeds |
| 05/20/2004 | US20040097375 Substituted fluoroalcoxyphenylsulfonylurea |
| 05/20/2004 | US20040096787 Color photography |
| 05/20/2004 | US20040096518 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/20/2004 | US20040094769 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylprimidines, and phenylquinolines and devices made with such compounds |
| 05/19/2004 | EP1419778A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/19/2004 | EP1419152A1 Hiv inhibiting pyrimidines derivatives |
| 05/19/2004 | EP1418919A2 The use of 5 fluorourcil, delivered by inotophoresis as an inhibitor of cell proliferation in the eye, bulbar and palpebral conjunctiva, eyelid, peri-orbital soft tissues and skin |
| 05/19/2004 | EP1418879A1 Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives |
| 05/19/2004 | EP1070692B1 Methods for highly selectively o-alkylating amide compounds with the use of copper salts |
| 05/19/2004 | EP0717736B1 Phosphorus derivatives to treat aids |
| 05/19/2004 | DE10251914A1 New 2,3-diphenyl-quinazoline-4-acetic acid derivatives, useful as antiviral agents, especially effective against human cytomegalovirus infections |
| 05/19/2004 | DE10251019A1 New pyrimidine-4,6-dicarboxamide derivatives, are selective collagenase inhibitors useful e.g. for treating degenerative joint diseases, connective tissue disorders or cancer |
| 05/19/2004 | DE10250708A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 05/19/2004 | DE10249946A1 Verfahren zur Herstellung von 2-Amino-4-chlor-6-alkoxypyrimidinen A process for the preparation of 2-amino-4-chloro-6-alkoxypyrimidinen |
| 05/19/2004 | CN1498212A New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors |
| 05/19/2004 | CN1496981A Cycloamine derivative and its use as medicine |
| 05/19/2004 | CN1150187C Use of selective antagonists of a1b-adrenergic receptor for improvement of sexual dysfunction |
| 05/19/2004 | CN1150171C Bicyclic heterocycles, pharmaceutical compositions containing these compounds,and processes for preparing them |
| 05/19/2004 | CN1150170C 3-(2-fluo-4,5,6-substituted Phenyl)-1,3-benzopyrimidine-4-one compound with herbiciding activity |
| 05/19/2004 | CN1149997C Medicine composition |
| 05/18/2004 | US6737425 N,N-substituted cyclic amine derivatives |
| 05/18/2004 | US6737423 Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising them |
| 05/18/2004 | CA2334317C Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 05/13/2004 | WO2004039786A1 Electroluminescent device |
| 05/13/2004 | WO2004039780A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |
| 05/13/2004 | WO2003079986A3 Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases |
| 05/13/2004 | US20040092746 Fungicides |
| 05/13/2004 | US20040092742 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
| 05/13/2004 | US20040092739 2,4-N,N*-Disubstituted quinazoline derivatives; annulation, cyclization; anticarcinogenic and antiinflammatory agents; autoimmune diseases |
| 05/13/2004 | US20040092539 Substituted 6-benzyl-4-oxopyrimidines, process for their preparation and pharmaceutical compositions containing them |
| 05/13/2004 | US20040092521 Antihistamines; central nervous system disorders |
| 05/13/2004 | US20040092520 Purine compounds and uses thereof |
| 05/13/2004 | US20040092515 Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors |
| 05/13/2004 | US20040092402 Pyrimidine derivatives and herbicides containing the same |
| 05/13/2004 | US20040091812 Lithographic printing plate precursors imageable elements; form dry films at ambient temperature |
| 05/13/2004 | US20040091421 The invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug; and (ii) a silicon component selected from one or more of: resorbable |
| 05/13/2004 | US20040089867 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 05/13/2004 | US20040089586 C-nitrosoaniline compounds and their blends as polymerization inhibitors |
| 05/12/2004 | EP1417264A1 Novel azo pigments |
| 05/12/2004 | EP1417207A2 Process for preparing 2-(4-pyridyl) amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin-7-ones |
| 05/12/2004 | EP1417182A1 Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 05/12/2004 | EP1417181A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417180A1 Preparation of aminopyrimidine compounds |
| 05/12/2004 | EP1416795A1 Compositions and methods for treatment of mitochondrial diseases |
| 05/12/2004 | EP1341785A4 HYDROLYSIS OF R(R*,R*)]-2-(4-FLUOROPHENYL)-$g(b),$g(d) -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- (PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE |
| 05/12/2004 | EP1066267B1 Substituted phenyl uracils |
| 05/12/2004 | EP1028111B1 Amide derivatives or salts thereof |
| 05/12/2004 | EP1026143B1 Novel liquid-crystal compounds having large negative value of permittivity anisotropy, liquid-crystal composition, and liquid-crystal display element |
| 05/12/2004 | CN1496355A Substituted fluoroalcoxyphenylsulfonylurea |
| 05/12/2004 | CN1495184A Substituted purine derivative, its preparation method, application and composition containing it |
| 05/12/2004 | CN1495175A Halogenated pyrimidine and its application for reducing parasite |
| 05/12/2004 | CN1495172A Irreversible inhibitor of tyrosine kinase |
| 05/12/2004 | CN1494906A Application of compound in preparation of medicine for preventing and curing multiple drug resistance |
| 05/12/2004 | CN1149265C Disazo dyestuffs |
| 05/12/2004 | CN1149214C Triazolo gerivatives and chemokine inhibitors containing the same as the active ingredient |
| 05/12/2004 | CN1149213C Substituted benzoylisoxazoles and the use thereof as herbicides |
| 05/12/2004 | CN1149196C Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 05/11/2004 | US6734304 Method for producing asymmetrical 4,6-bis(aryloxy)pyrimidine derivatives |
| 05/11/2004 | US6734303 Therapy for benign prostatic hyperplasia |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6734184 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) |
| 05/11/2004 | US6734183 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound |
| 05/11/2004 | US6733690 Acrylic ester polymers |
| 05/11/2004 | CA2199899C Process for the preparation of a 2-alkoxy-6-(trifluoro-methyl)pyrimidin-4-ol |
| 05/11/2004 | CA2083436C Process for the preparation of 5-substituted cytosines and other 4,5-disubstituted pyrimidin-2(1h)-ones, and intermediates arising in the course of this |
| 05/06/2004 | WO2004037823A1 Purine compounds and uses thereof as cannabinoid receptor ligands |
| 05/06/2004 | WO2004037800A1 Aryloxyalkylamine derivates as h3 receptor ligands |
| 05/06/2004 | WO2004037795A1 Method for the production of 2-amino-4-chloro-6-alkoxypyrimidines |
| 05/06/2004 | WO2004037772A1 Convenient and scalable synthesis of ethyl n-[(2-boc-amino) ethyl] glycinate and its hydrochloride salt |
| 05/06/2004 | WO2004037176A2 Quinazolinones and derivatives thereof as factor xa inhibitors |
| 05/06/2004 | WO2004037166A2 Therapeutic guanidines |
| 05/06/2004 | WO2003106428A8 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | US20040087798 Novel amide compounds |
| 05/06/2004 | US20040087789 Treating Alzheimer's disease, peripheral neuropathy, seizure disorder and/or diabetes |
| 05/06/2004 | US20040087659 Urea- and urethane-substituted acylureas, process for their preparation and their use |
| 05/06/2004 | US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics |
| 05/06/2004 | US20040087603 (2s) -2-amino-4-(2-amino-(3,4,5,6-tetrahydropyrimidin-4-yl) butanoyl and its use in cyclic and acyclic peptides |
| 05/06/2004 | US20040087601 Pyrimidine derivatives as IL-8 receptor antagonists |
| 05/06/2004 | US20040087585 Peptide deformylase inhibitors |
| 05/06/2004 | US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists |
| 05/06/2004 | US20040086907 Prevent Dna damage; antitumor, anticancer agents; blocking epidermal growth factor receptor |
| 05/06/2004 | EP1415987A1 Nitrogenous aromatic ring compounds |
| 05/06/2004 | EP1414825A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 05/06/2004 | EP1414810A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 05/06/2004 | EP1414807A1 Pyrimidine derivatives as selective inhibitors of cox-2 |